The HIF-α isoforms HIF-1α and HIF-2α exert opposing effects on ccRCC progression with HIF-1α acting as a tumor suppressor whereas HIF-2α exerts pro-oncogenic potential. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.